Illumina estimated last year that the total addressable market for DNA sequencing was $20 billion, and Illumina's Jay Flatley now tells Luke Timmerman at Forbes that "if you were to ask us what we think it is today, it's substantially bigger."
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.